BioPorto Company Description

BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally.

It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays.

BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.

BioPorto A/S

Country	Denmark
Founded	1917
Industry	Diagnostics & Research
Sector	Healthcare
Employees	29
CEO	Peter Eriksen

Contact Details

Address: Tuborg Havnevej 15, st. Hellerup, 2900 Denmark
Phone	45 45 29 00 00
Website	bioporto.com

Stock Details

Ticker Symbol	BIOPOR
Exchange	Copenhagen Stock Exchange
Fiscal Year	January - December
Reporting Currency	DKK
ISIN Number	DK0011048619
SIC Code	2836

Key Executives

Name	Position
Jeffrey N. Haas	President and Chief Executive Officer of BioPorto Inc.
Peter Moerch Eriksen B.B.A., BBA	Chief Executive Officer
Niels Hoey Nielsen	Executive Vice President and Chief Financial Officer
Dr. Lars Otto Uttenthal	Chief Scientific Officer
Gry Husby Larsen	Executive Vice President and Chief Legal Officer
Jennifer Zonderman	SVice President of Global Marketing and US Commercialization
Nis Kruse	Executive Vice President of Strategic Partnerships and GM of EMEA and APAC